| 000 | 01462cam a22003375i 4500 | ||
|---|---|---|---|
| 999 |
_c28616 _d28587 |
||
| 001 | 012360020 | ||
| 003 | EG-ScBUE | ||
| 005 | 20200830154131.0 | ||
| 008 | 950629s1995 waua f b 001 0 eng d | ||
| 020 | _a0841230587 | ||
| 020 | _a9780841230583 | ||
| 040 |
_aUk _beng _erda _cUk _dEG-ScBUE |
||
| 082 | 0 | 4 |
_a612 _bPEP _222 |
| 245 | 0 | 0 |
_aPeptide-based drug design : _bcontrolling transport and metabolism / _ceditors Michael D. Taylor, Gordon L. Amidon. |
| 264 | 1 |
_aWashington, DC : _bAmerican Chemical Society, _c1995. |
|
| 300 |
_axviii, 567 pages : _billustrations ; _c24 cm. |
||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_aunmediated _bn _2rdamedia |
||
| 338 |
_avolume _bnc _2rdacarrier |
||
| 490 | 0 | _aACS professional reference book. | |
| 504 | _aIncludes bibliographical references and index. | ||
| 520 | _aPresents a contemporary understanding of protein and peptide transport mechanisms and metabolism as a framework for facilitating the design and evaluation of peptidomimetic and other peptide-based drugs that combine high intrinsic potency with improved drug delivery properties. | ||
| 650 | 7 |
_aPeptide drugs _xPhysiological transport. _2BUEsh |
|
| 650 | 7 |
_aPeptide drugs _xMetabolism. _2BUEsh |
|
| 650 | 7 |
_aPeptides _xpharmacokinetics. _2BUEsh |
|
| 653 |
_bPPhrm _cAugust2020 |
||
| 700 | 1 |
_aTaylor, Michael D., _d1954- _eeditor. |
|
| 700 | 1 |
_aAmidon, Gordon L., _eeditor. |
|
| 710 | 2 |
_aAmerican Chemical Society, _eeditor. |
|
| 942 |
_2ddc _cBB |
||